Alta Schutte is a SHARP Professor and Theme Lead for Cardiac, Vascular and Metabolic Medicine at UNSW Sydney; and Professorial Fellow at The George Institute Australia. She holds honorary appointments at the North-West University and University of the Witwatersrand in South Africa. She is the Past President of the International Society of Hypertension, Company Secretary of the Australian Cardiovascular Alliance, and Co-Chair of the Australian National Hypertension Taskforce.

Alta is a leading researcher with extensive experience in clinical trials and population-based studies in the field of blood pressure, hypertension and cardiovascular health. She has been the Chief Investigator of several multidisciplinary studies, published >450 papers in the field, and supervised over 85 postgraduate students. She is Chief Investigator of several Australian-funded trials and is a NHMRC Investigator Grant Leadership Fellow.

She is involved in numerous international consortia, such as the Global Burden of Disease study, the NCD Risk Factor Collaboration, May Measurement Month global blood pressure screening campaign, World Health Organization working groups and the Lancet Commission of Hypertension. She is the senior author of the 2020 International Society of Hypertension Global Hypertension Guidelines. She is Associate Editor of the journal, Hypertension, and has received numerous international awards for her work, most recently the 2022 American Heart Association’s Harriet Dustan Award, and 2023 Peter Sleight Excellence Award in Hypertension Clinical Research from the World Hypertension League.

Dr Julieann Coombes identifies as a Gumbaynggir woman and highly skilled career professional with over 27 years nursing experience working in Aboriginal Community Health. She now focuses on improving health inequalities and outcomes for First Nations people and communities through research using Indigenous Knowledges (knowing, being and doing) and methodologies which empowers First Nations people’s voices in all her work. She has extensive experience in social and cultural determinants of health research, Indigenous methodologies and applies decolonising methods to all her research projects. Julieann has a commitment to ensure that all research with Aboriginal and Torres Strait Islander people is conducted in an ethical correct way and research integrity should be underpinned by equity, transparency, and self-determination.

Her work in Indigenous research methods, public health knowledge and qualitative research, work which is published, has been cited in policy, media, and academic publications.

Julieann received her PhD at University of Technology, Sydney and is a Senior Research Fellow for the Aboriginal and Torres Strait Islander Health Program at The George Institute for Global Health.

Anthony Sunjaya is a medical doctor from Indonesia and Honorary Fellow at the Respiratory and Health Systems Division, The George Institute for Global Health, UNSW Sydney, Australia. He is also an Honorary Research Fellow at the School of Public Health, Imperial College London and a Visiting Researcher at the Royal Brompton and Harefield Hospitals.

His research focuses on cardiorespiratory diseases, complex chronic diseases, primary care, and digital health especially the development, validation and translation of decision support systems, AI, and virtual care. He has a special interest in supporting universal health coverage, improving care, especially in low-resource settings and primary care through the use of innovative evidence-based solutions.

He is Chief Investigator of the Breathlessness Rapid Evaluation and THErapy (BREATHE) trial funded by the Australian Government Medical Research Future Fund to optimise the assessment and management of chronic breathlessness in primary care through implementation of a clinical decision support system for breathlessness across 40 GP practices in Australia building upon work during his PhD which was supported by the UNSW Scientia PhD program.

He is currently Chair, Primary Care SIG, Thoracic Society of Australia and New Zealand (TSANZ); Chair, Membership Committee, Society of Medical Decision Making (SMDM); Vice-Chair of the Digital Transformation Leadership working group in the International Society for Telemedicine and e-Health (ISfTeH), and Editorial Advisory Board member of the Annals of Family Medicine. He is also an active social entrepreneur and co-founder of BantingMed, a diabetes digital health startup.

He was previously President of Postgraduate Council UNSW and ASEAN Society UNSW, a delegate to the 2023 Group of 7 Youth Summit in Japan and has contributed to reports for the World Health Organization and Asthma Australia.

Associate Professor Brendon Neuen is Program Lead, Renal and Metabolic at The George Institute for Global Health and a Staff Specialist Nephrologist and Director of Kidney Trials at Royal North Shore Hospital. He graduated in medicine at James Cook University with 1st Class Honours and an Academic Medal; completed a Masters in Global Health and Epidemiology from the University of Oxford; a PhD from the University of New South Wales; and a Postdoctoral Fellowship at Brigham and Women's Hospital, Harvard Medical School. He is a Fellow of the Royal Australasian College of Physicians and a Fellow of the American Society of Nephrology.

He is an internationally recognised expert on cardio-kidney-metabolic health and serves as the Secretariat (Co-Chair) of the SGLT2 Inhibitor Meta-Analysis Cardio-Renal Trialists' Consortium (Smart C), which brings together data from over 90,000 patients from large-scale randomized trials to better understand the effects of this class of medicine in major patient groups. In addition, A/Prof Neuen is involved in the leadership of multiple ongoing international multi-centre randomized trials evaluating treatments to prevent kidney failure, cardiovascular events, or both. His work has directly informed more than 30 major international and national clinical practice guidelines, position papers and scientific statements which define best practice for the care of people with chronic kidney disease, including the Kidney Disease Improving Global Outcomes (KDIGO) Guidelines and the American Diabetes Association (ADA) Standards of Care.

A/Prof Neuen is the author of over 150 peer-reviewed publications in general medical journals including The Lancet, BMJ and Nature Medicine, and specialty journals including Lancet Diabetes and Endocrinology, Circulation, and the Journal of the American Society of Nephrology. He serves on the Editorial Boards of the American Society of Nephrology and Nephrology Dialysis and Transplantation (flagship journal of the European Renal Association). His work is supported by the National Health and Medical Research Council of Australia, New South Wales Health, the Ramaciotti Foundation, as well as philanthropic sources, and has been recognised through multiple awards, including the Royal Society of New South Wales Ida Browne Medal, and the American Heart Association's Paul Dudley White International Scholar Award.